{"id":37488,"date":"2020-11-10T11:42:53","date_gmt":"2020-11-10T16:42:53","guid":{"rendered":"https:\/\/reviewofmm.com\/?p=37488"},"modified":"2024-02-02T10:55:12","modified_gmt":"2024-02-02T15:55:12","slug":"coopervisions-brilliant-futures-myopia-management-program-expands-globally","status":"publish","type":"post","link":"https:\/\/reviewofmm.com\/coopervisions-brilliant-futures-myopia-management-program-expands-globally\/","title":{"rendered":"CooperVision\u2019s Brilliant Futures Myopia Management Program Expands Globally"},"content":{"rendered":"

November 10, 2020<\/strong><\/p>\n

\"\"Less than a year after debuting its\u00a0Brilliant Futures\u00a0 – Myopia Management Program<\/a>\u00a0featuring the\u00a0MiSight 1 day contact lens<\/a>\u00a0in the United States, CooperVision is now expanding the comprehensive approach to multiple countries, including the United Kingdom, Russia, Spain, Portugal, Canada, South Korea, and Taiwan.\u00a0This\u00a0seeks to create a new standard of care by creating the optimal environment for compliance, satisfaction, clinical outcomes and long-term loyalty.<\/p>\n

\u201cSeveral years from now, I believe we will look back at late 2020 as an inflection point in the global myopia management movement,\u201d said\u00a0Daniel McBride, president of CooperVision. \u201cNever before has there been this degree of momentum, driven in large part by substantial investments CooperVision is making in evidence-based science, innovative products, and comprehensive clinical and practice management education in the form of Brilliant Futures. Partnering with the optometry, ophthalmology and pediatric health communities, we have a real opportunity to change the lives of countless children in the decades ahead.\u201d<\/p>\n

Brilliant Futures has attracted robust participation during its selective U.S. rollout, with more than 1,500 eye care professionals now certified to fit MiSight 1 day. The innovative lens is the first and only soft contact lens the U.S. Food and Drug Administration has approved* for slowing the progression of myopia in children, who at initiation of treatment are 8-12 years of age.1<\/sup><\/span>\u00a0During the past several weeks, a\u00a0nationwide parent-focused advertising campaign<\/a>\u00a0featuring entrepreneur and actress Sarah Michelle Gellar\u2014believed to be possibly the world\u2019s largest-ever consumer myopia management awareness initiative\u2014further accelerated adoption.<\/p>\n

Complementing that success, Brilliant Futures is now coming to countries where MiSight 1 day has been previously available, such as the\u00a0United Kingdom<\/a>\u00a0in October.\u00a0Indie Grewal<\/a>, Optometrist and President of the British Contact Lens Association (BCLA), says myopia management \u201chas the potential to revolutionize\u00a0clinical outcomes\u00a0and can allow us to\u00a0change the trajectory of childhood myopia\u00a0in practice.\u201d \u00a0The program will also be introduced this month in\u00a0Spain<\/a>\u00a0and\u00a0Portugal<\/a>, which are current MiSight 1 day markets.<\/p>\n

In\u00a0Canada<\/a>, where MiSight 1 day prescribing has steadily grown in recent years, the Brilliant Futures program became available last week. A pilot study conducted by the Centre for Ocular Research & Education (CORE), the University of Waterloo\u2019s School of Optometry & Vision Science and the Canadian National Institute for the Blind determined that almost 30 percent of Canadian children aged 11-13 are myopic<\/a>.2<\/sup><\/span><\/p>\n

Likewise, the program is launching in countries concurrent with the first availability of MiSight 1 day. In\u00a0Russia<\/a>, this coincides with MiSight 1 day\u2019s new approval as a therapeutic contact lens and includes ECP-focused digital media and virtual events that began in late October. The lens is newly approved in South Korea for slowing myopia progression, with the program launch commencing this November.<\/p>\n

Brilliant Futures was unveiled in Taiwan<\/a>\u00a0in late September, where MiSight 1 day has become the first Taiwan Food and Drug Administration-approved product to control the progression of myopia in children. Myopia is estimated to affect approximately 960,000 Taiwanese elementary and middle school students.3<\/sup><\/span><\/p>\n

Advancing Myopia Management in China<\/u><\/p>\n

In China, myopia has increased at a significant rate in recent years. While only 4.7 percent of children less than seven years old are myopic,4\u00a0prevalence soars to\u00a0a stunning 80 to 90 percent<\/a>\u00a0once they reach 18 years of age.5<\/sup><\/span>\u00a0Equally concerning is a 11.7 percent rise in myopia during 2020 alone among children and teenagers, including a 15.2 percent increase in primary school students.6<\/sup><\/span><\/p>\n

In mid-October, the Center for Medical Device Evaluation of China\u2019s National Medical Products Administration (NMPA) granted priority review status to CooperVision\u2019s MiSight 1 day approval submission. In addition to ensuring faster evaluation of the application, the priority status provides more opportunities for company representatives to interact with the medical experts assessing MiSight\u00a01 day\u2019s safety and efficacy data.<\/p>\n

\u201cWe are experiencing a remarkable upturn in acknowledging that simply correcting for myopia is not enough, especially when we now have proven technologies to manage and help control its progression,\u201d said McBride. \u201cThere\u2019s still much to be done in establishing myopia management as the standard of care. With advancements such as Brilliant Futures\u2122 and the contributions of other like-minded innovators, healthcare professionals, government officials and professional associations, this goal is clearly within sight.\u201d<\/p>\n

*\u00a0 Indications for use: MiSight 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with \u2264 0.75 diopters of astigmatism. The lens is to be discarded after each removal.<\/p>\n

 <\/p>\n

References:<\/strong><\/p>\n

1<\/sup>\u00a0Chamberlain P, Logan N, Jones D, Gonzalez-Meijome J, Saw S-M, Young G. Clinical evaluation of a dual-focus myopia control 1 day soft contact lens: 6-year results (2020 American Academy of Optometry Annual Meeting).<\/p>\n

2<\/sup>\u00a0Yang, M., Luensmann, D., Fonn, D. et al.\u00a0Myopia prevalence in Canadian school children: a pilot study. Eye 32, 1042\u20131047 (2018). doi:10.1038\/s41433-018-0015-5<\/p>\n

3<\/sup>\u00a0Lin, Yuhua. \u201cChildren\u2019s Contact Lenses-A New Choice for Myopia Control.\u201d https:\/\/www.healthnews.com.tw\/news\/article\/47569<\/a> Accessed 24 Sept 2020.<\/p>\n

4<\/sup>\u00a0Dong L, Kang YK, Li Y, et al. Prevalence and Time Trends of Myopia in Children and Adolescents in China: A Systemic Review and Meta-Analysis. Retina 2020;40:399-411.<\/p>\n

5<\/sup>\u00a0Chen M, Wu A, Zhang L, et al. The increasing prevalence of myopia and high myopia among high school students in Fenghua city, eastern China: a 15-year population-based survey. BMC Ophthalmol. 2018;18(1):159. Published 2018 Jul 3. doi:10.1186\/s12886-018-0829-8<\/p>\n

6<\/sup>\u00a0Chinese Ministry of Education. Published 2020 Aug 8. Survey of 14,532 students from nine provinces with overall prevalence of myopia compared to 2019 Dec.<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

November 10, 2020 Less than a year after debuting its\u00a0Brilliant Futures\u00a0 – Myopia Management Program\u00a0featuring the\u00a0MiSight 1 day contact lens\u00a0in the United States, CooperVision is now expanding the comprehensive approach to multiple countries, including the United Kingdom, Russia, Spain, Portugal, Canada, South Korea, and Taiwan.\u00a0This\u00a0seeks to create a new standard of care by creating the optimal environment for compliance, satisfaction, clinical outcomes and long-term loyalty. \u201cSeveral years from now, I believe we will look back at late 2020 as an inflection point in the global myopia management movement,\u201d said\u00a0Daniel McBride, president of CooperVision. \u201cNever before has there been this degree of momentum, driven in large part by substantial investments CooperVision is making in evidence-based science, innovative products, and comprehensive clinical and practice management education in the form of Brilliant Futures. Partnering with the optometry, ophthalmology and pediatric health communities, we have a real opportunity to change the lives of countless children in the decades ahead.\u201d Brilliant Futures has attracted robust participation during its selective U.S. rollout, with more than 1,500 eye care professionals now certified to fit MiSight 1 day. The innovative lens is the first and only soft contact lens the U.S. Food and Drug Administration has approved* for slowing the progression of myopia in children, who at initiation of treatment are 8-12 years of age.1\u00a0During the past several weeks, a\u00a0nationwide parent-focused advertising campaign\u00a0featuring entrepreneur and actress Sarah Michelle Gellar\u2014believed to be possibly the world\u2019s largest-ever consumer myopia management awareness initiative\u2014further accelerated adoption. Complementing that success, Brilliant Futures is now coming to countries where MiSight 1 day has been previously available, such as the\u00a0United Kingdom\u00a0in October.\u00a0Indie Grewal, Optometrist and President of the British Contact Lens Association (BCLA), says myopia management \u201chas the potential to revolutionize\u00a0clinical outcomes\u00a0and can allow us to\u00a0change the trajectory of childhood myopia\u00a0in practice.\u201d \u00a0The program will also be introduced this month in\u00a0Spain\u00a0and\u00a0Portugal, which are current MiSight 1 day markets. In\u00a0Canada, where MiSight 1 day prescribing has steadily grown in recent years, the Brilliant Futures program became available last week. A pilot study conducted by the Centre for Ocular Research & Education (CORE), the University of Waterloo\u2019s School of Optometry & Vision Science and the Canadian National Institute for the Blind determined that almost 30 percent of Canadian children aged 11-13 are myopic.2 Likewise, the program is launching in countries concurrent with the first availability of MiSight 1 day. In\u00a0Russia, this coincides with MiSight 1 day\u2019s new […]<\/p>\n","protected":false},"author":295,"featured_media":37492,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1733],"tags":[1941,1736,1946,1735,2315],"yoast_head":"\nCooperVision\u2019s Brilliant Futures Myopia Management Program Expands Globally - Review of Myopia Management<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/reviewofmm.com\/coopervisions-brilliant-futures-myopia-management-program-expands-globally\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CooperVision\u2019s Brilliant Futures Myopia Management Program Expands Globally - Review of Myopia Management\" \/>\n<meta property=\"og:description\" content=\"November 10, 2020 Less than a year after debuting its\u00a0Brilliant Futures\u00a0 – Myopia Management Program\u00a0featuring the\u00a0MiSight 1 day contact lens\u00a0in the United States, CooperVision is now expanding the comprehensive approach to multiple countries, including the United Kingdom, Russia, Spain, Portugal, Canada, South Korea, and Taiwan.\u00a0This\u00a0seeks to create a new standard of care by creating the optimal environment for compliance, satisfaction, clinical outcomes and long-term loyalty. \u201cSeveral years from now, I believe we will look back at late 2020 as an inflection point in the global myopia management movement,\u201d said\u00a0Daniel McBride, president of CooperVision. \u201cNever before has there been this degree of momentum, driven in large part by substantial investments CooperVision is making in evidence-based science, innovative products, and comprehensive clinical and practice management education in the form of Brilliant Futures. Partnering with the optometry, ophthalmology and pediatric health communities, we have a real opportunity to change the lives of countless children in the decades ahead.\u201d Brilliant Futures has attracted robust participation during its selective U.S. rollout, with more than 1,500 eye care professionals now certified to fit MiSight 1 day. The innovative lens is the first and only soft contact lens the U.S. Food and Drug Administration has approved* for slowing the progression of myopia in children, who at initiation of treatment are 8-12 years of age.1\u00a0During the past several weeks, a\u00a0nationwide parent-focused advertising campaign\u00a0featuring entrepreneur and actress Sarah Michelle Gellar\u2014believed to be possibly the world\u2019s largest-ever consumer myopia management awareness initiative\u2014further accelerated adoption. Complementing that success, Brilliant Futures is now coming to countries where MiSight 1 day has been previously available, such as the\u00a0United Kingdom\u00a0in October.\u00a0Indie Grewal, Optometrist and President of the British Contact Lens Association (BCLA), says myopia management \u201chas the potential to revolutionize\u00a0clinical outcomes\u00a0and can allow us to\u00a0change the trajectory of childhood myopia\u00a0in practice.\u201d \u00a0The program will also be introduced this month in\u00a0Spain\u00a0and\u00a0Portugal, which are current MiSight 1 day markets. In\u00a0Canada, where MiSight 1 day prescribing has steadily grown in recent years, the Brilliant Futures program became available last week. A pilot study conducted by the Centre for Ocular Research & Education (CORE), the University of Waterloo\u2019s School of Optometry & Vision Science and the Canadian National Institute for the Blind determined that almost 30 percent of Canadian children aged 11-13 are myopic.2 Likewise, the program is launching in countries concurrent with the first availability of MiSight 1 day. In\u00a0Russia, this coincides with MiSight 1 day\u2019s new […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/reviewofmm.com\/coopervisions-brilliant-futures-myopia-management-program-expands-globally\/\" \/>\n<meta property=\"og:site_name\" content=\"Review of Myopia Management\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-10T16:42:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-02-02T15:55:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/reviewofmm.com\/wp-content\/uploads\/2020\/11\/GettyImages-1169668336.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2355\" \/>\n\t<meta property=\"og:image:height\" content=\"1273\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Robert Burke\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Robert Burke\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/reviewofmm.com\/coopervisions-brilliant-futures-myopia-management-program-expands-globally\/\",\"url\":\"https:\/\/reviewofmm.com\/coopervisions-brilliant-futures-myopia-management-program-expands-globally\/\",\"name\":\"CooperVision\u2019s Brilliant Futures Myopia Management Program Expands Globally - Review of Myopia Management\",\"isPartOf\":{\"@id\":\"https:\/\/reviewofmm.com\/#website\"},\"datePublished\":\"2020-11-10T16:42:53+00:00\",\"dateModified\":\"2024-02-02T15:55:12+00:00\",\"author\":{\"@id\":\"https:\/\/reviewofmm.com\/#\/schema\/person\/cbe4923ca5bdcf416c076d835288cd7d\"},\"breadcrumb\":{\"@id\":\"https:\/\/reviewofmm.com\/coopervisions-brilliant-futures-myopia-management-program-expands-globally\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/reviewofmm.com\/coopervisions-brilliant-futures-myopia-management-program-expands-globally\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/reviewofmm.com\/coopervisions-brilliant-futures-myopia-management-program-expands-globally\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/reviewofmm.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CooperVision\u2019s Brilliant Futures Myopia Management Program Expands Globally\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/reviewofmm.com\/#website\",\"url\":\"https:\/\/reviewofmm.com\/\",\"name\":\"Review of Myopia Management\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/reviewofmm.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/reviewofmm.com\/#\/schema\/person\/cbe4923ca5bdcf416c076d835288cd7d\",\"name\":\"Robert Burke\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/reviewofmm.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/dc944161fbaa7ac90485faba73bfa04c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/dc944161fbaa7ac90485faba73bfa04c?s=96&d=mm&r=g\",\"caption\":\"Robert Burke\"},\"sameAs\":[\"http:\/\/rlburkejr@cox.net\"],\"url\":\"https:\/\/reviewofmm.com\/author\/bob-burke\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CooperVision\u2019s Brilliant Futures Myopia Management Program Expands Globally - Review of Myopia Management","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/reviewofmm.com\/coopervisions-brilliant-futures-myopia-management-program-expands-globally\/","og_locale":"en_US","og_type":"article","og_title":"CooperVision\u2019s Brilliant Futures Myopia Management Program Expands Globally - Review of Myopia Management","og_description":"November 10, 2020 Less than a year after debuting its\u00a0Brilliant Futures\u00a0 – Myopia Management Program\u00a0featuring the\u00a0MiSight 1 day contact lens\u00a0in the United States, CooperVision is now expanding the comprehensive approach to multiple countries, including the United Kingdom, Russia, Spain, Portugal, Canada, South Korea, and Taiwan.\u00a0This\u00a0seeks to create a new standard of care by creating the optimal environment for compliance, satisfaction, clinical outcomes and long-term loyalty. \u201cSeveral years from now, I believe we will look back at late 2020 as an inflection point in the global myopia management movement,\u201d said\u00a0Daniel McBride, president of CooperVision. \u201cNever before has there been this degree of momentum, driven in large part by substantial investments CooperVision is making in evidence-based science, innovative products, and comprehensive clinical and practice management education in the form of Brilliant Futures. Partnering with the optometry, ophthalmology and pediatric health communities, we have a real opportunity to change the lives of countless children in the decades ahead.\u201d Brilliant Futures has attracted robust participation during its selective U.S. rollout, with more than 1,500 eye care professionals now certified to fit MiSight 1 day. The innovative lens is the first and only soft contact lens the U.S. Food and Drug Administration has approved* for slowing the progression of myopia in children, who at initiation of treatment are 8-12 years of age.1\u00a0During the past several weeks, a\u00a0nationwide parent-focused advertising campaign\u00a0featuring entrepreneur and actress Sarah Michelle Gellar\u2014believed to be possibly the world\u2019s largest-ever consumer myopia management awareness initiative\u2014further accelerated adoption. Complementing that success, Brilliant Futures is now coming to countries where MiSight 1 day has been previously available, such as the\u00a0United Kingdom\u00a0in October.\u00a0Indie Grewal, Optometrist and President of the British Contact Lens Association (BCLA), says myopia management \u201chas the potential to revolutionize\u00a0clinical outcomes\u00a0and can allow us to\u00a0change the trajectory of childhood myopia\u00a0in practice.\u201d \u00a0The program will also be introduced this month in\u00a0Spain\u00a0and\u00a0Portugal, which are current MiSight 1 day markets. In\u00a0Canada, where MiSight 1 day prescribing has steadily grown in recent years, the Brilliant Futures program became available last week. A pilot study conducted by the Centre for Ocular Research & Education (CORE), the University of Waterloo\u2019s School of Optometry & Vision Science and the Canadian National Institute for the Blind determined that almost 30 percent of Canadian children aged 11-13 are myopic.2 Likewise, the program is launching in countries concurrent with the first availability of MiSight 1 day. In\u00a0Russia, this coincides with MiSight 1 day\u2019s new […]","og_url":"https:\/\/reviewofmm.com\/coopervisions-brilliant-futures-myopia-management-program-expands-globally\/","og_site_name":"Review of Myopia Management","article_published_time":"2020-11-10T16:42:53+00:00","article_modified_time":"2024-02-02T15:55:12+00:00","og_image":[{"width":2355,"height":1273,"url":"https:\/\/reviewofmm.com\/wp-content\/uploads\/2020\/11\/GettyImages-1169668336.jpg","type":"image\/jpeg"}],"author":"Robert Burke","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Robert Burke","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/reviewofmm.com\/coopervisions-brilliant-futures-myopia-management-program-expands-globally\/","url":"https:\/\/reviewofmm.com\/coopervisions-brilliant-futures-myopia-management-program-expands-globally\/","name":"CooperVision\u2019s Brilliant Futures Myopia Management Program Expands Globally - Review of Myopia Management","isPartOf":{"@id":"https:\/\/reviewofmm.com\/#website"},"datePublished":"2020-11-10T16:42:53+00:00","dateModified":"2024-02-02T15:55:12+00:00","author":{"@id":"https:\/\/reviewofmm.com\/#\/schema\/person\/cbe4923ca5bdcf416c076d835288cd7d"},"breadcrumb":{"@id":"https:\/\/reviewofmm.com\/coopervisions-brilliant-futures-myopia-management-program-expands-globally\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/reviewofmm.com\/coopervisions-brilliant-futures-myopia-management-program-expands-globally\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/reviewofmm.com\/coopervisions-brilliant-futures-myopia-management-program-expands-globally\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/reviewofmm.com\/"},{"@type":"ListItem","position":2,"name":"CooperVision\u2019s Brilliant Futures Myopia Management Program Expands Globally"}]},{"@type":"WebSite","@id":"https:\/\/reviewofmm.com\/#website","url":"https:\/\/reviewofmm.com\/","name":"Review of Myopia Management","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/reviewofmm.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/reviewofmm.com\/#\/schema\/person\/cbe4923ca5bdcf416c076d835288cd7d","name":"Robert Burke","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/reviewofmm.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/dc944161fbaa7ac90485faba73bfa04c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/dc944161fbaa7ac90485faba73bfa04c?s=96&d=mm&r=g","caption":"Robert Burke"},"sameAs":["http:\/\/rlburkejr@cox.net"],"url":"https:\/\/reviewofmm.com\/author\/bob-burke\/"}]}},"parsely":{"version":"1.1.0","meta":{"@context":"https:\/\/schema.org","@type":"NewsArticle","headline":"CooperVision\u2019s Brilliant Futures Myopia Management Program Expands Globally","url":"https:\/\/reviewofmm.com\/coopervisions-brilliant-futures-myopia-management-program-expands-globally\/","mainEntityOfPage":{"@type":"WebPage","@id":"https:\/\/reviewofmm.com\/coopervisions-brilliant-futures-myopia-management-program-expands-globally\/"},"thumbnailUrl":"https:\/\/reviewofmm.com\/wp-content\/uploads\/2020\/11\/GettyImages-1169668336-150x150.jpg","image":{"@type":"ImageObject","url":"https:\/\/reviewofmm.com\/wp-content\/uploads\/2020\/11\/GettyImages-1169668336.jpg"},"articleSection":"Latest Myopia News","author":[{"@type":"Person","name":"Robert Burke"}],"creator":["Robert Burke"],"publisher":{"@type":"Organization","name":"Review of Myopia Management","logo":""},"keywords":["brilliant futures","daniel mcbride","indie grewal","misight 1 day","myopia news briefs\\"],"dateCreated":"2020-11-10T16:42:53Z","datePublished":"2020-11-10T16:42:53Z","dateModified":"2024-02-02T15:55:12Z"},"rendered":"<script type=\"application\/ld+json\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@type\":\"NewsArticle\",\"headline\":\"CooperVision\\u2019s Brilliant Futures Myopia Management Program Expands Globally\",\"url\":\"https:\\\/\\\/reviewofmm.com\\\/coopervisions-brilliant-futures-myopia-management-program-expands-globally\\\/\",\"mainEntityOfPage\":{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/reviewofmm.com\\\/coopervisions-brilliant-futures-myopia-management-program-expands-globally\\\/\"},\"thumbnailUrl\":\"https:\\\/\\\/reviewofmm.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/GettyImages-1169668336-150x150.jpg\",\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/reviewofmm.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/GettyImages-1169668336.jpg\"},\"articleSection\":\"Latest Myopia News\",\"author\":[{\"@type\":\"Person\",\"name\":\"Robert Burke\"}],\"creator\":[\"Robert Burke\"],\"publisher\":{\"@type\":\"Organization\",\"name\":\"Review of Myopia Management\",\"logo\":\"\"},\"keywords\":[\"brilliant futures\",\"daniel mcbride\",\"indie grewal\",\"misight 1 day\",\"myopia news briefs\\\\\"],\"dateCreated\":\"2020-11-10T16:42:53Z\",\"datePublished\":\"2020-11-10T16:42:53Z\",\"dateModified\":\"2024-02-02T15:55:12Z\"}<\/script>","tracker_url":"https:\/\/cdn.parsely.com\/keys\/reviewofmm.com\/p.js"},"cc_featured_image_caption":{"caption_text":"","source_text":"","source_url":""},"_links":{"self":[{"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/posts\/37488"}],"collection":[{"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/users\/295"}],"replies":[{"embeddable":true,"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/comments?post=37488"}],"version-history":[{"count":3,"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/posts\/37488\/revisions"}],"predecessor-version":[{"id":48717,"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/posts\/37488\/revisions\/48717"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/media\/37492"}],"wp:attachment":[{"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/media?parent=37488"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/categories?post=37488"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/tags?post=37488"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}